MYCN and neuroblastoma: RIP analysis further revealed that N6-methyladenosine modification in 3′-UTR of MYCN promoted its interaction with miR-98, suggesting that RNA m6A modification was required for miR-98/MYCN axis-mediated inhibition of neuroblastoma progression, and miR-98 might be novel targets for NB detection and treatment.